Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Technology Process of Trastuzumab

Trastuzumab

Base Information
  • Chemical Name:Trastuzumab
  • CAS No.:180288-69-1
  • Molecular Formula:C10H14N6O5
  • Molecular Weight:298.25536
  • Hs Code.:
  • Mol file:180288-69-1.mol
Trastuzumab

Synonyms:Herceptin;Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2 g1-chain anti-human p185c-erbB2receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain,dimer; Trastuzumab; rhumAb 4D5

Suppliers and Price of Trastuzumab
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • DC Chemicals
  • Trastuzumab
  • 002
  • $ 700.00
  • ChemScene
  • Trastuzumab 99.30%
  • 50mg
  • $ 4000.00
  • ChemScene
  • Trastuzumab 99.30%
  • 5mg
  • $ 660.00
  • ChemScene
  • Trastuzumab 99.30%
  • 1mg
  • $ 192.00
  • Biosynth Carbosynth
  • Trastuzumab - 20mg/ml in PBS
  • 10 mg
  • $ 420.00
  • Biosynth Carbosynth
  • Trastuzumab - 20mg/ml in PBS
  • 5 mg
  • $ 240.00
  • Biosynth Carbosynth
  • Trastuzumab - 20mg/ml in PBS
  • 2 mg
  • $ 120.00
  • Biosynth Carbosynth
  • Trastuzumab - 20mg/ml in PBS
  • 1 mg
  • $ 78.00
  • Biosynth Carbosynth
  • Trastuzumab - 20mg/ml in PBS
  • 25 mg
  • $ 900.00
  • American Custom Chemicals Corporation
  • TRASTUZUMAB 95.00%
  • 5MG
  • $ 498.70
Total 93 raw suppliers
Chemical Property of Trastuzumab
Chemical Property:
  • PSA：0.00000 
  • LogP:0.00000 
Purity/Quality:

99%, *data from raw suppliers

Trastuzumab *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Uses Trastuzumab is used to treat breast cancer. It is effective against tumors that overexpress the HER2/neu protien. As part of chemotherapy regimen for adjuvant treatment of lymph-node positive, HER2/neu positive cancer.
  • Indications The introduction of herceptin (Trastuzumab) into clinical practice for the treatment of breast cancer marks a major advance in the use of monoclonal antibody cancer therapy. Herceptin is a humanized antibody directed against the HER-2 antigen that is overexpressed on the tumor cell surface in approximately 25% of breast cancer patients. HER-2/neu/erbB2 overexpression marks an aggressive estrogen receptor–negative form of breast cancer. Therefore, a therapeutic agent selective for this target is particularly valuable. Herceptin is administered by intravenous infusion and in conjunction with paclitaxel can extend survival in patients with HER-2/neu/erbB2 overexpressing metastatic breast cancer.Herceptin use is associated with infusion- related hypotension, flushing and bronchoconstriction, and skin rash but no bone marrow toxicity. Herceptin appears to sensitize patients to cardiotoxicity, an important concern in patients also receiving doxorubicin.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 180288-69-1

Total 8 Pictures about this product